BioNexus Gene Lab Corp. (NASDAQ: BGLC) Stock Competitors & Peer Comparison
See BGLC's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Industrial - Distribution Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for BGLC and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| BGLC | $0.84 | -5.75% | 2M | -0.66 | -$1.27 | N/A |
| GWW | $1,472.92 | +1.74% | 69.4B | 34.01 | $43.31 | +0.67% |
| FAST | $54.84 | +0.49% | 62.9B | 44.23 | $1.24 | +1.82% |
| FERG | $259.29 | -0.25% | 50.2B | 22.16 | $11.70 | +1.35% |
| WCC | $316.72 | +0.08% | 15.4B | 18.51 | $17.11 | +0.61% |
| QXO | $13.73 | -0.40% | 14.2B | 91.50 | $0.15 | N/A |
| WSO-B | $313.24 | +3.28% | 13.2B | 26.52 | $11.81 | +4.03% |
| WSO | $311.26 | -1.63% | 13B | 27.50 | $11.32 | +4.03% |
| WCC-PA | $221.82 | +1.73% | 10.9B | 21.85 | $10.15 | +0.61% |
| AIT | $298.68 | +5.40% | 10.8B | 26.29 | $11.30 | +0.67% |
Stock Comparison
W.W. Grainger, Inc. (NYSE: GWW)
BGLC vs GWW Comparison November 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 2M. In comparison, GWW has a market cap of 69.4B. Regarding current trading prices, BGLC is priced at $0.84 on the NASDAQ, while GWW trades at $1,472.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -0.66, whereas GWW's P/E ratio is 34.01. In terms of profitability, BGLC's ROE is -0.33%, compared to GWW's ROE of +0.54%. Regarding short-term risk, BGLC is more volatile compared to GWW. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check GWW's competition here
Fastenal Company (NASDAQ: FAST)
BGLC vs FAST Comparison November 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 2M. In comparison, FAST has a market cap of 62.9B. Regarding current trading prices, BGLC is priced at $0.84 on the NASDAQ, while FAST trades at $54.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -0.66, whereas FAST's P/E ratio is 44.23. In terms of profitability, BGLC's ROE is -0.33%, compared to FAST's ROE of +0.35%. Regarding short-term risk, BGLC is more volatile compared to FAST. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check FAST's competition here
Ferguson Enterprises Inc. (NYSE: FERG)
BGLC vs FERG Comparison November 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 2M. In comparison, FERG has a market cap of 50.2B. Regarding current trading prices, BGLC is priced at $0.84 on the NASDAQ, while FERG trades at $259.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -0.66, whereas FERG's P/E ratio is 22.16. In terms of profitability, BGLC's ROE is -0.33%, compared to FERG's ROE of +0.34%. Regarding short-term risk, BGLC is more volatile compared to FERG. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check FERG's competition here
WESCO International, Inc. (NYSE: WCC)
BGLC vs WCC Comparison November 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 2M. In comparison, WCC has a market cap of 15.4B. Regarding current trading prices, BGLC is priced at $0.84 on the NASDAQ, while WCC trades at $316.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -0.66, whereas WCC's P/E ratio is 18.51. In terms of profitability, BGLC's ROE is -0.33%, compared to WCC's ROE of +0.15%. Regarding short-term risk, BGLC is more volatile compared to WCC. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check WCC's competition here
QXO, Inc. (NYSE: QXO)
BGLC vs QXO Comparison November 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 2M. In comparison, QXO has a market cap of 14.2B. Regarding current trading prices, BGLC is priced at $0.84 on the NASDAQ, while QXO trades at $13.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -0.66, whereas QXO's P/E ratio is 91.50. In terms of profitability, BGLC's ROE is -0.33%, compared to QXO's ROE of -0.05%. Regarding short-term risk, BGLC is more volatile compared to QXO. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check QXO's competition here
Watsco, Inc. (NYSE: WSO-B)
BGLC vs WSO-B Comparison November 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 2M. In comparison, WSO-B has a market cap of 13.2B. Regarding current trading prices, BGLC is priced at $0.84 on the NASDAQ, while WSO-B trades at $313.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -0.66, whereas WSO-B's P/E ratio is 26.52. In terms of profitability, BGLC's ROE is -0.33%, compared to WSO-B's ROE of +0.16%. Regarding short-term risk, BGLC is more volatile compared to WSO-B. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check WSO-B's competition here
Watsco, Inc. (NYSE: WSO)
BGLC vs WSO Comparison November 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 2M. In comparison, WSO has a market cap of 13B. Regarding current trading prices, BGLC is priced at $0.84 on the NASDAQ, while WSO trades at $311.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -0.66, whereas WSO's P/E ratio is 27.50. In terms of profitability, BGLC's ROE is -0.33%, compared to WSO's ROE of +0.16%. Regarding short-term risk, BGLC is more volatile compared to WSO. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check WSO's competition here
WESCO International, Inc. (NYSE: WCC-PA)
BGLC vs WCC-PA Comparison November 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 2M. In comparison, WCC-PA has a market cap of 10.9B. Regarding current trading prices, BGLC is priced at $0.84 on the NASDAQ, while WCC-PA trades at $221.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -0.66, whereas WCC-PA's P/E ratio is 21.85. In terms of profitability, BGLC's ROE is -0.33%, compared to WCC-PA's ROE of +0.15%. Regarding short-term risk, BGLC is more volatile compared to WCC-PA. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check WCC-PA's competition here
Applied Industrial Technologies, Inc. (NYSE: AIT)
BGLC vs AIT Comparison November 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 2M. In comparison, AIT has a market cap of 10.8B. Regarding current trading prices, BGLC is priced at $0.84 on the NASDAQ, while AIT trades at $298.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -0.66, whereas AIT's P/E ratio is 26.29. In terms of profitability, BGLC's ROE is -0.33%, compared to AIT's ROE of +0.23%. Regarding short-term risk, BGLC is more volatile compared to AIT. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check AIT's competition here
Core & Main, Inc. (NYSE: CNM)
BGLC vs CNM Comparison November 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 2M. In comparison, CNM has a market cap of 8.7B. Regarding current trading prices, BGLC is priced at $0.84 on the NASDAQ, while CNM trades at $47.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -0.66, whereas CNM's P/E ratio is 18.68. In terms of profitability, BGLC's ROE is -0.33%, compared to CNM's ROE of +0.23%. Regarding short-term risk, BGLC is more volatile compared to CNM. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check CNM's competition here
Pool Corporation (NASDAQ: POOL)
BGLC vs POOL Comparison November 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 2M. In comparison, POOL has a market cap of 7.8B. Regarding current trading prices, BGLC is priced at $0.84 on the NASDAQ, while POOL trades at $217.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -0.66, whereas POOL's P/E ratio is 20.09. In terms of profitability, BGLC's ROE is -0.33%, compared to POOL's ROE of +0.33%. Regarding short-term risk, BGLC is more volatile compared to POOL. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check POOL's competition here
MSC Industrial Direct Co., Inc. (NYSE: MSM)
BGLC vs MSM Comparison November 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 2M. In comparison, MSM has a market cap of 6.7B. Regarding current trading prices, BGLC is priced at $0.84 on the NASDAQ, while MSM trades at $119.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -0.66, whereas MSM's P/E ratio is 27.55. In terms of profitability, BGLC's ROE is -0.33%, compared to MSM's ROE of +0.16%. Regarding short-term risk, BGLC is more volatile compared to MSM. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check MSM's competition here
Xometry, Inc. (NASDAQ: XMTR)
BGLC vs XMTR Comparison November 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 2M. In comparison, XMTR has a market cap of 6.7B. Regarding current trading prices, BGLC is priced at $0.84 on the NASDAQ, while XMTR trades at $119.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -0.66, whereas XMTR's P/E ratio is 216.93. In terms of profitability, BGLC's ROE is -0.33%, compared to XMTR's ROE of -0.04%. Regarding short-term risk, BGLC is less volatile compared to XMTR. This indicates lower risk in terms of short-term price fluctuations for BGLC.Check XMTR's competition here
SiteOne Landscape Supply, Inc. (NYSE: SITE)
BGLC vs SITE Comparison November 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 2M. In comparison, SITE has a market cap of 5B. Regarding current trading prices, BGLC is priced at $0.84 on the NASDAQ, while SITE trades at $116.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -0.66, whereas SITE's P/E ratio is 31.85. In terms of profitability, BGLC's ROE is -0.33%, compared to SITE's ROE of +0.10%. Regarding short-term risk, BGLC is more volatile compared to SITE. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check SITE's competition here
Resideo Technologies, Inc. (NYSE: REZI)
BGLC vs REZI Comparison November 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 2M. In comparison, REZI has a market cap of 3B. Regarding current trading prices, BGLC is priced at $0.84 on the NASDAQ, while REZI trades at $19.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -0.66, whereas REZI's P/E ratio is 7.20. In terms of profitability, BGLC's ROE is -0.33%, compared to REZI's ROE of +0.15%. Regarding short-term risk, BGLC is more volatile compared to REZI. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check REZI's competition here
Dnow Inc. (NYSE: DNOW)
BGLC vs DNOW Comparison November 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 2M. In comparison, DNOW has a market cap of 2.5B. Regarding current trading prices, BGLC is priced at $0.84 on the NASDAQ, while DNOW trades at $13.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -0.66, whereas DNOW's P/E ratio is 25.44. In terms of profitability, BGLC's ROE is -0.33%, compared to DNOW's ROE of -0.09%. Regarding short-term risk, BGLC is more volatile compared to DNOW. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check DNOW's competition here
DXP Enterprises, Inc. (NASDAQ: DXPE)
BGLC vs DXPE Comparison November 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 2M. In comparison, DXPE has a market cap of 2.4B. Regarding current trading prices, BGLC is priced at $0.84 on the NASDAQ, while DXPE trades at $155.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -0.66, whereas DXPE's P/E ratio is 27.03. In terms of profitability, BGLC's ROE is -0.33%, compared to DXPE's ROE of +0.19%. Regarding short-term risk, BGLC is more volatile compared to DXPE. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check DXPE's competition here
Global Industrial Co (NYSE: GIC)
BGLC vs GIC Comparison November 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 2M. In comparison, GIC has a market cap of 1.8B. Regarding current trading prices, BGLC is priced at $0.84 on the NASDAQ, while GIC trades at $47.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -0.66, whereas GIC's P/E ratio is 21.40. In terms of profitability, BGLC's ROE is -0.33%, compared to GIC's ROE of +0.28%. Regarding short-term risk, BGLC is more volatile compared to GIC. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check GIC's competition here
Distribution Solutions Group, Inc. (NASDAQ: DSGR)
BGLC vs DSGR Comparison November 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 2M. In comparison, DSGR has a market cap of 1.6B. Regarding current trading prices, BGLC is priced at $0.84 on the NASDAQ, while DSGR trades at $34.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -0.66, whereas DSGR's P/E ratio is 32.99. In terms of profitability, BGLC's ROE is -0.33%, compared to DSGR's ROE of +0.02%. Regarding short-term risk, BGLC is more volatile compared to DSGR. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check DSGR's competition here
ADI Global Distribution Inc. (NYSE: ADIG)
BGLC vs ADIG Comparison November 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 2M. In comparison, ADIG has a market cap of 1.3B. Regarding current trading prices, BGLC is priced at $0.84 on the NASDAQ, while ADIG trades at $19.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -0.66, whereas ADIG's P/E ratio is -5.60. In terms of profitability, BGLC's ROE is -0.33%, compared to ADIG's ROE of +0.00%. Regarding short-term risk, BGLC is more volatile compared to ADIG. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check ADIG's competition here
Systemax Inc. (NYSE: SYX)
BGLC vs SYX Comparison November 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 2M. In comparison, SYX has a market cap of 1.3B. Regarding current trading prices, BGLC is priced at $0.84 on the NASDAQ, while SYX trades at $35.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -0.66, whereas SYX's P/E ratio is N/A. In terms of profitability, BGLC's ROE is -0.33%, compared to SYX's ROE of +0.46%. Regarding short-term risk, BGLC is more volatile compared to SYX. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check SYX's competition here
Lawson Products, Inc. (NASDAQ: LAWS)
BGLC vs LAWS Comparison November 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 2M. In comparison, LAWS has a market cap of 796.8M. Regarding current trading prices, BGLC is priced at $0.84 on the NASDAQ, while LAWS trades at $40.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -0.66, whereas LAWS's P/E ratio is N/A. In terms of profitability, BGLC's ROE is -0.33%, compared to LAWS's ROE of +0.02%. Regarding short-term risk, BGLC is more volatile compared to LAWS. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check LAWS's competition here
Titan Machinery Inc. (NASDAQ: TITN)
BGLC vs TITN Comparison November 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 2M. In comparison, TITN has a market cap of 558.4M. Regarding current trading prices, BGLC is priced at $0.84 on the NASDAQ, while TITN trades at $23.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -0.66, whereas TITN's P/E ratio is -10.18. In terms of profitability, BGLC's ROE is -0.33%, compared to TITN's ROE of -0.10%. Regarding short-term risk, BGLC is more volatile compared to TITN. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check TITN's competition here
BlueLinx Holdings Inc. (NYSE: BXC)
BGLC vs BXC Comparison November 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 2M. In comparison, BXC has a market cap of 499.6M. Regarding current trading prices, BGLC is priced at $0.84 on the NASDAQ, while BXC trades at $63.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -0.66, whereas BXC's P/E ratio is 47.40. In terms of profitability, BGLC's ROE is -0.33%, compared to BXC's ROE of -0.01%. Regarding short-term risk, BGLC is more volatile compared to BXC. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check BXC's competition here
EVI Industries, Inc. (AMEX: EVI)
BGLC vs EVI Comparison November 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 2M. In comparison, EVI has a market cap of 287.6M. Regarding current trading prices, BGLC is priced at $0.84 on the NASDAQ, while EVI trades at $22.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -0.66, whereas EVI's P/E ratio is 46.19. In terms of profitability, BGLC's ROE is -0.33%, compared to EVI's ROE of +0.05%. Regarding short-term risk, BGLC is less volatile compared to EVI. This indicates lower risk in terms of short-term price fluctuations for BGLC.Check EVI's competition here
Alta Equipment Group Inc. (NYSE: ALTG-PA)
BGLC vs ALTG-PA Comparison November 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 2M. In comparison, ALTG-PA has a market cap of 205.4M. Regarding current trading prices, BGLC is priced at $0.84 on the NASDAQ, while ALTG-PA trades at $25.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -0.66, whereas ALTG-PA's P/E ratio is -9.98. In terms of profitability, BGLC's ROE is -0.33%, compared to ALTG-PA's ROE of +4.56%. Regarding short-term risk, BGLC is more volatile compared to ALTG-PA. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check ALTG-PA's competition here
Alta Equipment Group Inc. (NYSE: ALTG)
BGLC vs ALTG Comparison November 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 2M. In comparison, ALTG has a market cap of 197M. Regarding current trading prices, BGLC is priced at $0.84 on the NASDAQ, while ALTG trades at $5.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -0.66, whereas ALTG's P/E ratio is -2.38. In terms of profitability, BGLC's ROE is -0.33%, compared to ALTG's ROE of +4.56%. Regarding short-term risk, BGLC is less volatile compared to ALTG. This indicates lower risk in terms of short-term price fluctuations for BGLC.Check ALTG's competition here
Zone Frontier Inc. (AMEX: ZONE)
BGLC vs ZONE Comparison November 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 2M. In comparison, ZONE has a market cap of 23.3M. Regarding current trading prices, BGLC is priced at $0.84 on the NASDAQ, while ZONE trades at $2.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -0.66, whereas ZONE's P/E ratio is -2.24. In terms of profitability, BGLC's ROE is -0.33%, compared to ZONE's ROE of -1.74%. Regarding short-term risk, BGLC is less volatile compared to ZONE. This indicates lower risk in terms of short-term price fluctuations for BGLC.Check ZONE's competition here
Rectitude Holdings Ltd Ordinary Shares (NASDAQ: RECT)
BGLC vs RECT Comparison November 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 2M. In comparison, RECT has a market cap of 19.2M. Regarding current trading prices, BGLC is priced at $0.84 on the NASDAQ, while RECT trades at $1.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -0.66, whereas RECT's P/E ratio is 6.20. In terms of profitability, BGLC's ROE is -0.33%, compared to RECT's ROE of +0.13%. Regarding short-term risk, BGLC is less volatile compared to RECT. This indicates lower risk in terms of short-term price fluctuations for BGLC.Check RECT's competition here
Ten-League International Holdings Limited Ordinary Shares (NASDAQ: TLIH)
BGLC vs TLIH Comparison November 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 2M. In comparison, TLIH has a market cap of 16.1M. Regarding current trading prices, BGLC is priced at $0.84 on the NASDAQ, while TLIH trades at $5.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -0.66, whereas TLIH's P/E ratio is 4.17. In terms of profitability, BGLC's ROE is -0.33%, compared to TLIH's ROE of +0.28%. Regarding short-term risk, BGLC is less volatile compared to TLIH. This indicates lower risk in terms of short-term price fluctuations for BGLC.Check TLIH's competition here
JBDI Holdings Limited (NASDAQ: JBDI)
BGLC vs JBDI Comparison November 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 2M. In comparison, JBDI has a market cap of 10.9M. Regarding current trading prices, BGLC is priced at $0.84 on the NASDAQ, while JBDI trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -0.66, whereas JBDI's P/E ratio is 230.00. In terms of profitability, BGLC's ROE is -0.33%, compared to JBDI's ROE of +0.06%. Regarding short-term risk, BGLC is less volatile compared to JBDI. This indicates lower risk in terms of short-term price fluctuations for BGLC.Check JBDI's competition here
Creative Global Technology Holdings Limited Ordinary Shares (NASDAQ: CGTL)
BGLC vs CGTL Comparison November 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 2M. In comparison, CGTL has a market cap of 2.8M. Regarding current trading prices, BGLC is priced at $0.84 on the NASDAQ, while CGTL trades at $2.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -0.66, whereas CGTL's P/E ratio is 17.16. In terms of profitability, BGLC's ROE is -0.33%, compared to CGTL's ROE of -0.12%. Regarding short-term risk, BGLC is less volatile compared to CGTL. This indicates lower risk in terms of short-term price fluctuations for BGLC.Check CGTL's competition here
WF International Limited Ordinary Shares (NASDAQ: WXM)
BGLC vs WXM Comparison November 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 2M. In comparison, WXM has a market cap of 2.5M. Regarding current trading prices, BGLC is priced at $0.84 on the NASDAQ, while WXM trades at $2.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -0.66, whereas WXM's P/E ratio is -0.29. In terms of profitability, BGLC's ROE is -0.33%, compared to WXM's ROE of -1.01%. Regarding short-term risk, BGLC is less volatile compared to WXM. This indicates lower risk in terms of short-term price fluctuations for BGLC.Check WXM's competition here
Houston Wire & Cable Company (NASDAQ: HWCC)
BGLC vs HWCC Comparison November 2026
BioNexus Gene Lab Corp. (NASDAQ: BGLC) plays a significant role within the Industrials sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, BGLC stands at 2M. In comparison, HWCC has a market cap of 0. Regarding current trading prices, BGLC is priced at $0.84 on the NASDAQ, while HWCC trades at $5.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
BGLC currently has a P/E ratio of -0.66, whereas HWCC's P/E ratio is N/A. In terms of profitability, BGLC's ROE is -0.33%, compared to HWCC's ROE of -0.13%. Regarding short-term risk, BGLC is more volatile compared to HWCC. This indicates higher risk in terms of short-term price fluctuations for BGLC.Check HWCC's competition here